INS and metabolic dysfunction-associated steatotic liver disease: Reduced insulin sensitivity, which is often observed in persons with NAFLD, may boost hepatic fat accumulation by increasing free fatty acid release from adipose tissue, and by the effect of hyperinsulinemia on anabolic processes [6].